LAVAL, QC, Nov. 12 /CNW/ - BioSyntech, Inc. (“BioSyntech” or “the Company”) (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial results for the three and six-month periods ended September 30, 2007.
